tsh biopharmoration Ltd Cash Flow Reinvestment Rate
tsh biopharmoration Ltd cash flow reinvestment rate. tsh biopharmoration Ltd (8432) has a Cash Flow Reinvestment Rate of 0.08x as of June 2025, reinvesting NT$3.27 Million (capex NT$3.27 Million ) from operating cash flow of NT$42.55 Million. Explore 8432 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of tsh biopharmoration Ltd (2017–2024)
Cash flow reinvestment rate of tsh biopharmoration Ltd from 2017 to 2024. Historical reinvestment intensity for tsh biopharmoration Ltd across 8 annual periods. Explore tsh biopharmoration Ltd (8432) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
tsh biopharmoration Ltd Cash Flow Reinvestment Rate by Year (2017–2024)
tsh biopharmoration Ltd cash flow reinvestment rate by year from 2017 to 2024. Year-by-year capital reinvestment analysis for tsh biopharmoration Ltd. For the full cash flow conversion analysis, see tsh biopharmoration Ltd (8432) cash conversion ratio.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.71x | NT$130.68 Million | NT$183.77 Million | NT$2.74 Million | ▼ -85.5% |
| 2023 | 4.92x | NT$166.57 Million | NT$33.87 Million | NT$5.56 Million | ▲ +297.7% |
| 2022 | 1.24x | NT$42.48 Million | NT$34.35 Million | NT$18.73 Million | ▲ +479.4% |
| 2021 | 0.21x | NT$14.66 Million | NT$68.71 Million | NT$382.00K | ▼ -98.9% |
| 2020 | 19.96x | NT$231.81 Million | NT$11.61 Million | NT$2.38 Million | ▲ +7837.8% |
| 2019 | 0.25x | NT$22.30 Million | NT$88.65 Million | NT$3.00 Million | ▼ -90.3% |
| 2018 | 2.59x | NT$162.16 Million | NT$62.62 Million | NT$5.88 Million | ▲ +74.7% |
| 2017 | 1.48x | NT$120.29 Million | NT$81.13 Million | NT$4.57 Million | — |